Motivatrx LLC is categorized under Commercial Biotechnical Research in San Diego, CA and active since 2007.
Motivatrx LLC was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Chin-Chih Chiang at the company’s single location by writing to 9863 Pcf Heights Boulevard # G, San Diego, California CA 92121 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Motivatrx LLC |
| Contact Person: | Chin-Chih Chiang |
| Address: | 9863 Pcf Heights Boulevard # G, San Diego, California 92121 |
| Website Address: | motivatrx.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Motivatrx LLC was started in 2007 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chin-Chih Chiang for inquiries that concern Motivatrx LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Motivatrx LLC can be found at the coordinates 32.899969,-117.189034 as well as the street address 9863 Pcf Heights Boulevard # G in San Diego, California 92121.
For its online presence, you may visit Motivatrx LLC’s website at motivatrx.com and engage with its social media outlets through on Twitter and on Facebook.